These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38739313)

  • 41. [Is scleroderma an allo-immune disease?].
    Cosnes A; Cabane J; Humbert P; Emmerich J; Bagot M; Maquart FX; Aractingi S
    Ann Dermatol Venereol; 1999 Mar; 126(3):291-4. PubMed ID: 10394448
    [No Abstract]   [Full Text] [Related]  

  • 42. Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma).
    Inoshita T; Whiteside TL; Rodnan GP; Taylor FH
    J Lab Clin Med; 1981 Feb; 97(2):264-77. PubMed ID: 6450255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Masking of pan-T-cell markers in patients with autoimmune diseases].
    Grunow R; Volk HD; Schwaab J; Barthelmes H; Lande L; von Baehr R
    Dermatol Monatsschr; 1987; 173(7):390-9. PubMed ID: 3498654
    [No Abstract]   [Full Text] [Related]  

  • 44. The vascular defect in scleroderma (systemic sclerosis).
    Leroy EC
    Acta Med Scand Suppl; 1987; 715():165-7. PubMed ID: 3495959
    [No Abstract]   [Full Text] [Related]  

  • 45. [Quantitative evaluation of T-, B- and 0-lymphocyte populations in focal scleroderma].
    Fedorova EG
    Vestn Dermatol Venerol; 1980 Jun; (6):17-9. PubMed ID: 6967244
    [No Abstract]   [Full Text] [Related]  

  • 46. Human postthymic precursor cells in health and disease. VII. Immunoregulatory circuits of the peripheral blood mononuclear cells from patients with progressive systemic sclerosis.
    Alarcón-Segovia D; Palacios R; Ibáñez de Kasep G
    J Clin Lab Immunol; 1981 May; 5(3):143-8. PubMed ID: 6453999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet contributions to the pathogenesis of systemic sclerosis.
    Postlethwaite AE; Chiang TM
    Curr Opin Rheumatol; 2007 Nov; 19(6):574-9. PubMed ID: 17917538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of the alveolar macrophages and T lymphocytes in 15 patients with systemic sclerosis.
    Czirják L; Koncz A; Varga I; Dévényi K; Kumánovics G; Szücs G
    Clin Rheumatol; 1999; 18(5):357-63. PubMed ID: 10524548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis.
    Gustafsson R; Tötterman TH; Klareskog L; Hällgren R
    Ann Rheum Dis; 1990 Jan; 49(1):40-5. PubMed ID: 2138008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Systemic scleroderma].
    Sollberg S; Krieg T
    Hautarzt; 1995 Aug; 46(8):587-601; quiz 600-1. PubMed ID: 7558832
    [No Abstract]   [Full Text] [Related]  

  • 51. Subpopulations of human T lymphocytes. IX. Imbalance of T cell subpopulations in patients with progressive systemic sclerosis.
    Gupta S; Malaviya AN; Rajagopalan P; Good RA
    Clin Exp Immunol; 1979 Nov; 38(2):342-7. PubMed ID: 316754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cytokines and T cell differentiation in systemic sclerosis].
    Trad S; Granel B; Parizot C; Dorgham K; Hanslik T; Marie I; Amoura Z
    Rev Med Interne; 2011 Aug; 32(8):472-85. PubMed ID: 20850209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma.
    Alcocer-Varela J; Martinez-Cordero E; Alarcon-Segovia D
    Clin Exp Immunol; 1985 Mar; 59(3):666-72. PubMed ID: 3872755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Scleroderma. A model for fibrosis.
    Fleischmajer R; Perlish JS; Duncan M
    Arch Dermatol; 1983 Dec; 119(12):957-62. PubMed ID: 6360053
    [No Abstract]   [Full Text] [Related]  

  • 55. Calcium Influx Kinetics and the Characteristics of Potassium Channels in Peripheral T Lymphocytes in Systemic Sclerosis.
    Toldi G; Legány N; Ocsovszki I; Balog A
    Pathobiology; 2020; 87(5):311-316. PubMed ID: 32911471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased interferon-gamma (IFN-gamma) levels produced in vitro by alloactivated T lymphocytes in systemic sclerosis and Raynaud's phenomenon.
    Molteni M; Della Bella S; Mascagni B; Bazzi S; Zulian C; Compasso S; Lessi M; Scorza R
    Clin Exp Immunol; 1999 Apr; 116(1):164-8. PubMed ID: 10209521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis.
    Ferrarini M; Steen V; Medsger TA; Whiteside TL
    Clin Exp Immunol; 1990 Mar; 79(3):346-52. PubMed ID: 1969335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vgamma9+ gammadelta T cells in systemic sclerosis patients are numerically and functionally preserved and induce fibroblast apoptosis.
    Bendersky A; Markovits N; Bank I
    Immunobiology; 2010 May; 215(5):380-94. PubMed ID: 19589616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-1 production by mononuclear cells from patients with scleroderma.
    Sandborg CI; Berman MA; Andrews BS; Friou GJ
    Clin Exp Immunol; 1985 May; 60(2):294-302. PubMed ID: 3874022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of IL-13 in systemic sclerosis.
    Fuschiotti P
    Cytokine; 2011 Dec; 56(3):544-9. PubMed ID: 21920770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.